Hypertension and experimental stroke therapies

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 8, 2013, Pages 1141-1147

  O'Collins, Victoria E ^a   Donnan, Geoffrey A ^a   MacLeod, Malcolm R ^b   Howells, David W ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

acute stroke; animal models; brain ischemia; hypertension; neuroprotection

Indexed keywords

ADRENOMEDULLIN; ALBUMIN; ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGUANIDINE; ANGIOTENSIN II ANTAGONIST; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CITICOLINE; DEXANABINOL; DEXTRO ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISUFENTON SODIUM; DIURETIC AGENT; DIZOCILPINE; ENLIMOMAB; HALOTHANE; IFENPRODIL; ISOFLURANE; ISRADIPINE; METHOHEXITAL; MINOCYCLINE; N(G) NITROARGININE METHYL ESTER; NICARDIPINE; PENTOBARBITAL; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIHYPERTENSIVE THERAPY; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; DRUG EFFICACY; EXPERIMENTAL MODEL; EXPERIMENTAL THERAPY; HYPERBARIC OXYGEN; HYPERCAPNIA; HYPERTENSION; INDUCED HYPOTHERMIA; KINESIOTHERAPY; META ANALYSIS (TOPIC); NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW (TOPIC);

ANIMALS; ANTIHYPERTENSIVE AGENTS; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; RATS; RATS, INBRED SHR; RATS, WISTAR; STROKE;

EID: 84881175699     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.88     Document Type: Review

References (26)

1. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376: 112-123.
2. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 227-276.
3. Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S et al. The angiotensinreceptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011; 377: 741-750.
4. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004; 35: 520-526.
5. Thomas D, Bath PM, Lees K, Hextall EJ, Skene A, Pocock S et al. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior anti hypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1: 245-249.
6. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 2008; 39: 2824-2829.
7. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-2250.
8. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol 2006; 59: 467-477.
9. O'Collins VE, Macleod MR, Donnan GA, Howells DW. Evaluation of combination therapy in animal models of cerebral ischemia. J Cereb Blood Flow Metab 2012; 32: 585-597.
10. Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004; 35: 1203-1208.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
12. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18: 2693-2708.
13. STB-42. Stata Technical Bulletin (STB) 42. Texas A & M University: College Station, Texas, 1998.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ 2003; 327: 557-560.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
17. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455-463.
18. Bailey EL, Wardlaw JM, Graham D, Dominiczak AF, Sudlow CL, Smith C. Cerebral small vessel endothelial structural changes predate hypertension in strokeprone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5-to 21-week-old rats. Neuropathol Appl Neurobiol 2011; 37: 711-726.
19. Salat DH, Williams VJ, Leritz EC, Schnyer DM, Rudolph JL, Lipsitz LA et al. Interindividual variation in blood pressure is associated with regional white matter integrity in generally healthy older adults. Neuroimage 2012; 59: 181-192.
20. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Group ISTC. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33: 1315-1320.
21. Coyle P, Jokelainen PT. Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive stroke-prone rats (SHRSP) and Wistar Kyoto (WKY) rats. Stroke 1983; 14: 605-611.
22. McGill J, Gallagher L, Carswell H, Irving E, Dominiczak A, Macrae I. Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat. Stroke 2005; 36: 135-141.
23. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009; 40: 2442-2449.
24. Shinohara Y, Origasa H. Post-stroke pneumonia prevention by angiotensinconverting enzyme inhibitors: results of a meta-analysis of five studies in Asians. Adv Ther 2012; 29: 900-912.
25. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 1998; 39: 89-105.
26. Dornas WC, Silva ME. Animal models for the study of arterial hypertension. J Biosci 2011; 36: 731-737.